Yudi Her Oktaviono, Yudi Her
Department Of Cardiology & Vascular Medicine, Faculty Of Medicine, Universitas Airlangga, Dr. Soetomo Hospital, Surabaya

Published : 24 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 24 Documents
Search

Case Report: RETROGRADE APPROACH FOR CTO LESIONS: SERIAL CASE Oktaviono, Yudi Her
Folia Medica Indonesiana Vol. 52 No. 4 (2016): OCTOBER - DECEMBER 2016
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (315.158 KB) | DOI: 10.20473/fmi.v52i4.5479

Abstract

Chronic total occlusion recanalization still represents the final frontier in percutaneous coronary intervention. Successful revascularization is associated with improved long-term survival, reduced symptoms, improved left ventricular function and reduced need for coronary bypass surgery. Retrograde chronic total occlusion recanalization has recently become an essential complement to the classic antegrade approach. Retrograde approach through the collateral channel has been recently proposed and has the potential to improve the success rate of percutaneous coronary intervention (PCI) in chronic total occlusion (CTO) lession of the coronary arteries. We report several cases of successful CTO recanalization procedure using retrograde approach in Soetomo Hospital.
Thrombocytopenia in a Patient Undergoing Primary Percutaneous Coronary Intervention Oktaviono, Yudi Her; Meuthia, Feranti
Folia Medica Indonesiana Vol. 55 No. 1 (2019): March
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (225.434 KB) | DOI: 10.20473/fmi.v55i1.24434

Abstract

Thrombocytopenia is a common abnormality in patients presenting with acute coronary syndrome. Baseline thrombocytopenia in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention is associated with early adverse events, related to both ischemia and bleeding. Treatment for acute coronary syndrome usually involves antiplatelet, anticoagulant, antithrombotic therapy, and the performance of percutaneous coronary intervention. The safety of antiplatelet therapy and percutaneous coronary intervention patients who have acute coronary syndrome and thrombocytopenia is unknown, and there are no guidelines or randomized studies that specifically suggest a treatment approach in such patients. One of the institutions in Italy recommends medical and interventional strategy with radialis as first choice for access site, bare metal stent (BMS) implantation, followed by double antiplatelet therapy (DAPT) for one month. After DAPT discontinuation, at least one antiplatelet drug (aspirin) is recommended for life.
Case Report: The Role of Intravascular Ultrasonography in Patients Underwent Percutaneous Coronary Intervention Oktaviono, Yudi Her; Putri, Alisia Yuana
Folia Medica Indonesiana Vol. 55 No. 4 (2019): December
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (888.406 KB) | DOI: 10.20473/fmi.v55i4.24517

Abstract

Intravascular ultrasonography (IVUS) has an important role as a complimentary diagnostic tool in percutaneous coronary intervention procedure. IVUS provides valuable information regarding coronary vessel lumen and dimension and also plaque burden and its characteristic. The main use of IVUS in PCI is to guide the choose of interventional strategies to optimize stent deployment. Since drug eluting stent (DES) has promised to decrease the incidence in stent restenosis and stent thrombosis than bare metal stent, but neither the suboptimal results nor the complication after stenting with DES is still high. Thus, optimization of stent deployment under IVUS guidance is important in cases to decrease stent failure after PCI procedure, as well as to decrease complication rate after stenting in order to decrease mortality rate caused by coronary artery disease. We present here the use of IVUS guidance in a 43 and 46 year-old man underwent PCI.
Diagnosis dan Terapi Non-farmakologis pada Hipertensi Pandit Bagus Tri Saputra; Ariikah Dyah Lamara; Mahendra Eko Saputra; Rakha Achmad Maulana; Irien Eko Hermawati; Hanang Anugrawan Achmad; Rachmat Ageng Prastowo; Yudi Her Oktaviono
Cermin Dunia Kedokteran Vol 50 No 6 (2023): Edisi CME
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v50i6.624

Abstract

Pada tahun 2019, hipertensi diderita oleh 1,28 milyar jiwa di seluruh dunia dan diperkirakan terus meningkat setiap tahun. Saat ini, hipertensi masih menjadi salah satu penyebab utama morbiditas dan mortalitas global. Terdapat perubahan paradigma diagnosis hipertensi menjadi lebih direkomendasikan dengan pemeriksaan tekanan darah di luar klinik (out-of-office blood pressure measurement) berupa pemeriksaan tekanan darah ambulatoar (PTDA) jika fasilitas memadai atau pemeriksaan tekanan darah di rumah (PTDR) pada fasilitas lebih terbatas. Manajemen pasien hipertensi berfokus pada kontrol tekanan darah untuk meningkatkan kualitas hidup serta menurunkan angka kecacatan dan kematian dengan terapi farmakologis dan non-farmakologis. Terapi non-farmakologis telah terbukti membantu mengontrol tekanan darah, menurunkan morbiditas dan mortalitas, baik individu hipertensi maupun individu normal.   In 2019, hypertension was suffered by 1.28 billion people worldwide and is expected to increase every year. Hypertension is still one of the main causes of global morbidity and mortality. There is a paradigm shift that diagnosis of hypertension is more recommended by out-of-office blood pressure measurement. Blood pressure measurements outside clinic can be done with ambulatory blood pressure or home blood pressure in limited facilities. Management of hypertensive patients focuses on blood pressure control with pharmacological and non-pharmacological method to improve quality of life, as well as to reduce morbidity and mortality. Non-pharmacological approach has been proven to optimize blood pressure control, to reduce morbidity and mortality in both hypertensive and normal individuals.